LEXINGTON, MA – November 17, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that the paper, “
March 1, 2016
Quanterix announces that it has been selected by Fast Company as one of the world’s top 10 most innovative companies in 2016 in Sports – the only medical technology company to be recognized in this category.
September 26, 2016
Quanterix announces that it is making a strategic investment in ImmunArray, a molecular diagnostics company advancing the development of novel, multi-marker tests for complex diseases with compelling levels of accuracy.
Discussion to be led by Cedars-Sinai Medical Center Professor of Medicine Dr. Jennifer E. Van Eyk
Quanterix is sponsoring a webinar by Dr. Jennifer E. Van Eyk, professor of medicine, Cedars-Sinai Medical Center, on the need for precise protein quantification and identification in personalized medicine on Tuesday, April 18, 2017 from 1:00 – 2:00 p.m. EST.
July 18, 2017
Dr. Daniel Sikkema joins Quanterix as Vice President of Accelerator Services to lead the growth of the company’s contract research lab and support precision health advances across a wide range of therapeutic categories
CAMBRIDGE, MA – November 11, 2008 – Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board (SAB). Dr. Corn is a Professor in the Departments of Chemistry and Biomedical Engineering at the University of…